Millstone Evans Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Sell
9,613
-637
-6% -$148K 1.32% 13
2026
Q1
$2.51M Buy
10,250
+36
+0.4% +$8.38K 1.5% 11
2025
Q4
$2.11M Buy
10,214
+226
+2% +$44.7K 1.24% 13
2025
Q3
$1.85M Sell
9,988
-25
-0.2% -$4.28K 1.18% 14
2025
Q2
$1.53M Sell
10,013
-9
-0.1% -$1.38K 1.04% 18
2025
Q1
$1.66M Hold
10,022
1.13% 16
2024
Q4
$1.45M Buy
+10,022
New +$1.55M 0.99% 20

Other funds holding JNJ

Millstone Evans Group's JNJ Position: Q2 2026 in Review

Millstone Evans Group reduced its Johnson & Johnson (JNJ) stake by 6.2% in Q2 2026, selling an estimated $148K and leaving 9,613 shares worth $2.44M. The position accounts for 1.32% of the portfolio, ranked #13.

Millstone Evans Group first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.51M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Millstone Evans Group held 9,613 shares of Johnson & Johnson worth $2.44M as of Q2 2026.
  • Millstone Evans Group sold 637 Johnson & Johnson shares in Q2 2026, an estimated $148K.
  • Johnson & Johnson made up 1.32% of Millstone Evans Group's portfolio in Q2 2026, its #13 holding.
  • Millstone Evans Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's Johnson & Johnson position peaked at $2.51M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.